...
首页> 外文期刊>Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology >Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury.
【24h】

Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury.

机译:靶向的细胞内过氧化氢酶递送保护新生大鼠心肌细胞免受缺氧-再氧化和缺血-再灌注损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypoxia followed by reoxygenation and ischemia reperfusion cause cell death in neonatal rat ventricular myocytes primarily through the generation of oxidative stress. Extracellular catalase has not been effective in reducing or eliminating ischemia reperfusion- or hypoxia-reoxygenation-induced cell death due both to extracellular degradation and to poor cellular uptake. AIMS: (1) To determine whether a cell-penetrating catalase derivative with enhanced peroxisome targeting efficiency (catalase-SKL) increases intracellular levels of the antioxidant enzyme in neonatal rat ventricular myocytes; and (2) to determine whether catalase-SKL protects against both hypoxia-reoxygenation and ischemia reperfusion injury. METHODS: Neonatal rat ventricular myocytes were subjected to 3 or 6 h of hypoxia-reoxygenation or to 1 h of ischemia reperfusion. Extracellular catalase concentration, activity, and subcellular distribution were determined using standard techniques. Reactive oxygen species and related oxidative stress were visualized using 2',7'-dichlorofluorescin diacetate. Cell death was measured using trypan blue exclusion or lactate dehydrogenase release assays. RESULTS: Extracellular catalase activity was higher in (catalase-SKL) transduced myocytes, was concentrated in a membranous cellular fraction, and potently inhibited oxidative stress. In contrast to nontransducible (unmodified) extracellular catalase, catalase-SKL-treated myocytes were protected against both hypoxia-reoxygenation and ischemia reperfusion. CONCLUSIONS: (1) Catalase-SKL increased myocyte extracellular catalase content and activity and dramatically increased resistance to hydrogen peroxide-induced oxidation; (2) catalase-SKL protects against both hypoxia-reoxygenation and ischemia reperfusion; (3) catalase-SKL may represent a new therapeutic approach to protect hearts against myocardial hypoxia-reoxygenation or ischemia reperfusion.
机译:缺氧后再充氧和缺血再灌注主要通过产生氧化应激在新生大鼠心室肌细胞中引起细胞死亡。细胞外过氧化氢酶不能有效减少或消除由于细胞外降解和不良细胞摄取而引起的缺血再灌注或缺氧再加氧引起的细胞死亡。目的:(1)确定具有增强的过氧化物酶体靶向效率的穿透细胞的过氧化氢酶衍生物(catalase-SKL)是否增加新生大鼠心室肌细胞中抗氧化酶的细胞内水平; (2)确定过氧化氢酶-SKL是否能同时防止缺氧-复氧和缺血再灌注损伤。方法:对新生大鼠心室肌细胞进行3或6小时的缺氧复氧或1小时的缺血再灌注。使用标准技术确定细胞外过氧化氢酶浓度,活性和亚细胞分布。使用2',7'-二氯荧光素二乙酸酯观察活性氧和相关的氧化应激。使用锥虫蓝排除法或乳酸脱氢酶释放测定法测量细胞死亡。结果:(catalase-SKL)转导的心肌细胞中的细胞过氧化氢酶活性更高,集中在膜细胞部分,并有效抑制氧化应激。与不可转导的(未修饰的)细胞外过氧化氢酶相反,过氧化氢酶-SKL处理的心肌细胞具有抗缺氧-再充氧和缺血再灌注的功能。结论:(1)过氧化氢酶-SKL增加了肌细胞胞外过氧化氢酶的含量和活性,并显着增加了对过氧化氢诱导的氧化的抵抗力; (2)过氧化氢酶-SKL可以防止缺氧-再氧化和缺血再灌注; (3)过氧化氢酶-SKL可能代表了一种保护心脏免于心肌缺氧-再加氧或缺血再灌注的新治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号